Related Experiment Videos

Retinoic acid inhibits human melanoma tumor cell invasion

W R Wood1, E A Seftor, D Lotan

  • 1Department of Anatomy, College of Medicine, University of Arizona, Tucson 85724.

Anticancer Research
|March 1, 1990
PubMed

Insights

Retinoic acid inhibits melanoma cell invasion by reducing collagenase and plasminogen activator activity. This anticancer effect involves changes in oncogene expression and the cytoskeleton.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Retinoids exhibit anticancer properties, but their precise mechanisms of action remain largely unelucidated.
  • Melanoma cell invasion is a critical factor in metastasis and patient prognosis.

Purpose of the Study:

  • To investigate the anti-invasive effects of retinoic acid (RA) on human melanoma cells in vitro.
  • To elucidate the molecular mechanisms underlying RA's inhibition of melanoma cell invasion.

Main Methods:

  • In vitro invasion assays using matrigel-coated filters.
  • Analysis of collagenolytic enzyme activity and plasminogen activator (PA) activity.
  • Gene expression analysis of oncogenes (c-myc, c-fos, c-jun) and cytoskeletal proteins (beta-actin, vimentin) via Northern blot and SDS-PAGE.

Main Results:

  • Retinoic acid significantly inhibited melanoma cell invasion in a time-dependent manner.
  • RA treatment reduced the secretion and activity of collagenolytic enzymes and decreased PA activity (primarily tPA).
  • Observed heterogeneous changes in c-myc, c-fos, and c-jun mRNA levels, alongside decreased beta-actin and increased vimentin expression.

Conclusions:

  • Retinoic acid suppresses melanoma cell invasion by inhibiting type IV collagenolytic and PA activities.
  • These effects are likely mediated by complex interactions involving oncogenic factors and alterations in cytoskeletal protein expression.

Related Concept Videos